LIRAGLUTIDE IMPROVES BOTH DIABETIC NEPHROPATHY AND CARDIOMYOPATHY IN THE SDT FATTY RAT, A CARDIORENAL MODEL OF TYPE 2 DIABETES
Back
Abstract Number
WCN23-0212
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
LIRAGLUTIDE IMPROVES BOTH DIABETIC NEPHROPATHY AND CARDIOMYOPATHY IN THE SDT FATTY RAT, A CARDIORENAL MODEL OF TYPE 2 DIABETES
Co-authors
Briandphd, F.(1)*;Shinohara, M.(2);Kageyama, Y.(2);Sulpice, T.(1);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)Physiogenex, Research, Escalquens, France;(2)Clea Japan Inc., Business Development, Tokyo, Japan;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/1832594c6e240b84fd12bf972de20dce.pdf
Audio File
if any